{"status":"OK","data":{"advertisement":{"id":245703,"title":"ZAPYTANIE OFERTOWE nr 43/2024/Z/KONGO","partial_offer_allowed":false,"publication_date":"2024-03-21","submission_deadline":"2024-03-29 23:59:59","planned_sign_date":"2024-04-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-30 00:00:03","contact_persons":[{"id":368,"forename":"Anna","surname":"Za\u0142\u0119cka","phone_number":"","email":"anna.zalecka@celonpharma.com","created_by":null,"created_at":"2026-07-01 13:24:58","modified_at":"2026-07-01 13:24:58","modified_by":null}],"orders":[{"id":398745,"estimated_value":null,"order_items":[{"id":449665,"description":"1.\t\tL-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-, 98% (CAS: 133407-82-6)\t100 mg\t1\n2.\t\tIxazomib, 98% (CAS: 1072833-77-2)\t250 mg\t1\n3.\t\tBortezomib, 98% (CAS: 179324-69-7)\t1 g\t1\n4.\t\t(S)-4-Amino-2-hydroxybutanoic acid, 98% (CAS: 40371-51-5)\t50 g\t1\n5.\t\t4-Amino-2-hydroxybutanoic acid, 98% (CAS: 13477-53-7)\t50 g\t1\n6.\t\t27-Amino-4,7,10,13,16,19,22,25-octaoxaheptacosanoic acid, 97% (CAS: 756526-04-2)\t10 g\t1\n7.\t\t1-Aminooctaethylene Glycol, 97% (CAS: 352439-37-3)\t10 g\t1\n8.\t\t1-Amino-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 97% (CAS: 905954-28-1)\t10 g\t1\n9.\t\t2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol, 98% (CAS: 86770-74-3)\t50 g\t1\n10.\t\t3-(2-(2-Aminoethoxy)ethoxy)propanoic acid, 98% (CAS: 791028-27-8)\t25 g\t1\n11.\t\tMethyl 1,2,3,4-tetra-O-acetyl-\u03b2-D-glucopyranuronate, 97% (CAS: 7355-18-2)\t50 g\t1\n12.\t\t4. N-Methyl-N-[[[4-[[L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide, 98% (CAS: 644981-35-1)\t10 g\t1\n13.\t\tL-Valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide, 98% (CAS: 159857-79-1)\t10 g\t1\n14.\t\t11,12-Didehydro-\u03b3-oxo-dibenz[b,f]azocine-5(6H)-butanoic acid 2,5-dioxo-1-pyrrolidinyl ester, 95% (CAS:1353016-71-3)\t50 g\t1\n15.\t\t(4-Aminophenyl)methanol, 98% (CAS: 623-04-1)\t100 g\t1","warranty_period":null,"cpv_items":[{"id":3148,"code":"33696500-0","name":"Odczynniki laboratoryjne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"nowodworski","commune":"Czosn\u00f3w","locality":"Kazu\u0144 Nowy","created_by":null,"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-21 14:54:17","modified_by":null,"id":504113,"type":{"id":1,"name":"adres"},"group_uuid":"14a724e2-6f94-48e8-8cdc-3bcc9106a663"}],"participation_conditions":[],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-21 14:54:17","modified_by":null,"group_uuid":"a98701a8-735d-46d1-91c9-eaf4a6e8318e"}],"evaluation_criteria":[{"id":685521,"price_criterion":true,"description":"Cena 100%","created_by":null,"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-21 14:54:17","modified_by":null,"group_uuid":"63dff916-1429-4a03-bec2-d74ddffeafce"}],"is_variant":false,"title":"Odczynniki chemiczne","order_node":{"id":302373},"created_by":null,"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-21 14:54:17","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":656084,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-21 14:54:17","modified_by":{"id":177,"contact_persons":[]},"id":246253},"advertisement":{"id":186866,"number":"2024-177-186866","publication_date":"2024-03-21","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-21 14:54:17","modified_at":"2024-03-30 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[245703],"enrollment":null,"projects":[{"id":43069,"name":"Opracowanie pierwszego w klasie innowacyjnego immunokoniugatu o dzia\u0142aniu immunomoduluj\u0105cym i cytotoksycznym, jako kandydata na lek w terapii nowotwor\u00f3w","number":"A032/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-A032/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2023-12-06 11:00:15","modified_at":"2023-12-06 11:00:15","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":245703,"publication_date":"2024-03-21"},"id":1270838,"name":"ZAPYTANIE OFERTOWE","file":{"id":1416871,"name":"ZO_43_2024_Z_KONGO.pdf","created_at":"2024-03-21 14:53:39","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1416871"},"group_uuid":"769372cb-b271-4d81-a017-0dc232e1a8d2"},{"origin":{"id":245703,"publication_date":"2024-03-21"},"id":1270839,"name":"za\u0142. 1 - O\u015bwiadczenie o braku powi\u0105za\u0144","file":{"id":1416872,"name":"zal. 1 Oswiadczenie o braku powiazan FENG.pdf","created_at":"2024-03-21 14:53:52","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1416872"},"group_uuid":"1ce91091-5162-4a0e-836a-2f4891ead477"},{"origin":{"id":245703,"publication_date":"2024-03-21"},"id":1270840,"name":"RfQ","file":{"id":1416873,"name":"RfQ_43_2024_Z_KONGO.pdf","created_at":"2024-03-21 14:54:03","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1416873"},"group_uuid":"034904d4-63bb-40d5-a2ba-ede6278e381e"},{"origin":{"id":245703,"publication_date":"2024-03-21"},"id":1270841,"name":"Att. 1 Statement","file":{"id":1416875,"name":"att. 1 Statement \u2014 FENG.pdf","created_at":"2024-03-21 14:54:13","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1416875"},"group_uuid":"fe332a15-91c1-41fb-b2f0-d8e2e3acdc02"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}